Video Endoscopy Systems in Texas

Synthesis Health Intelligence Inc. develops an intelligent, cloud-native radiology platform designed to enhance workflow efficiency and reporting accuracy for hospitals, imaging centers, and teleradiology groups. The company addresses the critical radiologist shortage through comprehensive software solutions that integrate PACS replacement, reporting, speech recognition, AI integration, and image management. The Synthesis platform includes a diagnostic and enterprise image viewer (Synthesis VISION, FDA 510(k) cleared), unified worklist management, automated exam assignment, DICOM-compliant cloud archive, and advanced clinical reporting with SynthSpeech cloud-based speech recognition. The platform incorporates the proprietary Synthesis Playbook—standardized modalities, exam types, body regions, report templates, and hanging protocols—enabling seamless deployment across multiple institutions. Key capabilities include AI-based auto-impression and report corrections, breast imaging workflows, structured reporting interoperability, intelligent data normalization, and multi-tenant architecture for healthcare networks. The company integrates FDA-cleared third-party AI applications and provides built-in training, peer review, critical results tracking, and messaging. Infrastructure complies with HIPAA and PIPEDA, with platform security certified to HITRUST, SOC2, and ISO 27001 standards. Synthesis markets to imaging healthcare professionals (radiologists, technologists, administrators) and OEMs seeking cloud migration, legacy PACS overlay or replacement, and cost-effective AI deployment at scale.

Perimeter Medical Imaging AI is a medical technology company specializing in intraoperative optical coherence tomography (OCT) imaging systems enhanced with artificial intelligence for cancer surgery guidance. The company's FDA-cleared Perimeter S-Series OCT and next-generation B-Series OCT with ImgAssist AI software provide real-time, cellular-level margin visualization during breast-conserving surgery and other oncologic procedures. These systems enable surgeons to identify residual tumor tissue and assess surgical margins with unprecedented clarity, reducing re-excision rates and repeat surgeries. Perimeter's technology leverages advanced optical imaging and machine learning algorithms to deliver actionable intraoperative insights, helping surgical teams close with confidence while improving patient outcomes and lowering healthcare costs. The company operates from Dallas, Texas with headquarters in Toronto, Canada.

Varian Medical Systems, a Siemens Healthineers company, specializes in cancer care solutions across the entire patient journey, including radiation oncology, adaptive therapy, interventional oncology, and image-guided treatment systems. Primary product lines include TrueBeam and Edge external beam radiotherapy systems with integrated image-guided capabilities, Ethos Therapy (an AI-powered adaptive intelligence platform for personalized cancer delivery), Halcyon platform for streamlined radiotherapy, RapidArc dynamic treatment planning, HyperSight imaging solution for enhanced real-time visualization, and IntelliBlate microwave ablation for interventional oncology. The company develops treatment planning software, dose calculation engines, and connected workflows for cancer centers. Products are FDA 510(k) cleared and serve hospital radiation oncology departments, cancer centers, and specialty clinics. Varian provides training, webinars, clinical education, and ongoing customer support. The organization conducts research in radiotherapy innovation and maintains partnerships with clinical institutions globally.

Instapath Inc. manufactures rapid tissue imaging systems that digitize pathology specimens without destructive processing. The company offers a portfolio of fluorescence microscopy platforms designed for point-of-procedure tissue analysis, fresh-specimen imaging, and remote scanning services. Neo is a Class I medical device employing patented fluorescence microscopy to determine tissue composition immediately during procedures without sample alteration. Luci enables large-specimen imaging of fresh, fixed, or frozen samples without laborious histological processing or tissue loss, preserving samples for downstream molecular and analytical testing. LuciNow is a complementary remote slide-scanning service offering on-demand specimen analysis through a service-based model. The technology addresses pathology workflows in surgical, research, and diagnostic settings where rapid, non-destructive tissue characterization is critical. Instapath's systems are designed for hospitals, research institutions, and clinical laboratories requiring immediate tissue assessment without compromising sample integrity for subsequent testing. The company targets physicians, researchers, and healthcare organizations seeking to reduce turnaround time and eliminate tissue waste in pathology workflows.